Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 12, 2021 at 03:41 am EDT
Share
Chimin Health Management Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 534.196 million compared to CNY 343.229 million a year ago. Operating income was CNY 125.734 million compared to CNY 17.233 million a year ago. Net income was CNY 105.133 million compared to CNY 3.595 million a year ago. Basic earnings per share from continuing operations was CNY 0.32 compared to CNY 0.01 a year ago.
Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.
CHIMIN HEALTH MANAGEMENT CO., LTD. 
